REVIEW
Accepted on 23 Jan 2025
New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma
doi 10.3389/fimmu.2025.1438001
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Combination Immunotherapy and Immune Response Assessment of Brain Tumours
Combination Immunotherapy and Immune Response Assessment of Brain Tumours
5,975
Total downloads
17k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 14 Nov 2024
Case report: Intravascular large B cell lymphoma mimicking acute demyelinating encephalomyelitis after SARS-CoV-2 reinfection: diagnostic value of advanced MRI techniques and the literature review with the assistance of ChatGPT
doi 10.3389/fimmu.2024.1478163
- 914 views
CASE REPORT
Published on 14 Oct 2024
Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report
doi 10.3389/fimmu.2024.1434697
- 739 views
ORIGINAL RESEARCH
Published on 11 Sep 2024
Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study
doi 10.3389/fimmu.2024.1447879
- 751 views
CASE REPORT
Published on 10 May 2024
Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC
doi 10.3389/fonc.2024.1390343
- 635 views
CASE REPORT
Published on 04 Apr 2024
Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas
doi 10.3389/fimmu.2024.1369972
- 1,090 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Feb 2024
Integrated multiomic analysis reveals disulfidptosis subtypes in glioblastoma: implications for immunotherapy, targeted therapy, and chemotherapy
doi 10.3389/fimmu.2024.1362543
- 2,363 views
- 1 citation
ORIGINAL RESEARCH
Published on 05 Jan 2024
IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy
doi 10.3389/fimmu.2023.1338244
- 3,920 views
- 4 citations
REVIEW
Published on 20 Oct 2023
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma
doi 10.3389/fimmu.2023.1261257
- 3,142 views
- 7 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 17kTopic views
- 10kArticle views
- 5,975Article downloads